Aktuellt (på finska)
Aktuellt (på finska)
Publikationer
Publikationer
Rapporter
Böcker
Promemoria
Working Papers
Akademiska publikationer
Andra publikationer
Prognoser
Forskning
Personal
All personal
Forskare
Direktion
Kommunikation och andra services
Etla
Om Etla
Målsättning
Organisationen
Historik
Kontaktuppgifter
Fi
Eng
Sv
Sök på sidan
1.1.2003
Publikationer
Price Markups and R&D Inputs: The Pharmaceutical Industry in Finland and the USA
Hermans Raine
Linnosmaa Ismo
Information om publikationen
Serie
Discussion Papers no. 877
Sidor
18
Pris
10 €
Tillgänglighet av tryckt version
Tillgänglig
Språk
Engelska
Ladda ner
Ladda ner (Engelska)
Diskussionsämnen
Föregående
Nästa
Aktuellt
28.04.2025
Publikationer
Rapporter
163
Public Sector Wage-Setting: Can an Export-Led Labour Market Model Be Created in Finland?
Kauhanen Antti
The Finnish labour market model has been undergoing a transformation since 2007, and the role of the public
sector
22.04.2025
Publikationer
Promemoria
158
Ex-Nokians Eagerly Became Entrepreneurs and Business Angels: Nokia Experience Fueled Rapid Growth of Startups’ Turnovers
Rouvinen Petri
Breznitz Dan
Pajarinen Mika
This brief examines entrepreneurship and business angel activity in Finland following the challenges Nokia’s mobile telephony business faced
in
17.04.2025
Publikationer
Promemoria
157
Public Finance Perspective from Recent Studies on Finnish Pharmaceutical Markets
Jokelainen Antto
Markkanen Jaakko
Siikanen Markku
Toivanen Otto
Petteri Orpo’s government program plans to reform pharmaceutical and pharmacy regulation in Finland. In this memo, we review
some
15.04.2025
Publikationer
Rapporter
162
A Clean Tariff? Effects and Challenges of EU CBAM
Kaitila Ville
Kuusi Tero
Pajarinen Mika
Wang Maria
This study examines the impacts of the European Union’s Carbon Border Adjustment Mechanism (CBAM) on corporate costs, adaptation
strategies,
